Chlorpyrifos inhibits cell proliferation through ERK1/2 phosphorylation in breast cancer cell lines

被引:51
|
作者
Ventura, Clara [1 ]
Venturino, Andres [2 ]
Miret, Noelia [3 ]
Randi, Andrea [3 ]
Rivera, Elena [1 ]
Nunez, Mariel [1 ]
Cocca, Claudia [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Lab Radioisotopos, RA-1113 Buenos Aires, DF, Argentina
[2] Univ Nacl Comahue, CONICET, IDEPA, Lab Invest Bioquim & Quim Medio Ambiente LIBIQUIM, Neuquen, Argentina
[3] Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Lab Efectos Biol Contaminantes Ambientales, RA-1053 Buenos Aires, DF, Argentina
关键词
Organophosphorus; Chlorpyrifos; Breast cancer cell lines; ERK1/2; Oxidative stress; Hydroxide peroxide; REACTIVE OXYGEN; OXIDATIVE STRESS; APOPTOSIS; PESTICIDE; ALPHA; DEATH; ACTIVATION; EXPOSURE; RECEPTOR; PATHWAY;
D O I
10.1016/j.chemosphere.2014.07.088
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
It is well known the participation of oxidative stress in the induction and development of different pathologies including cancer, diabetes, neurodegeneration and respiratory disorders among others. It has been reported that oxidative stress may be induced by pesticides and it could be the cause of health alteration mediated by pollutants exposure. Large number of registered products containing chlorpyrifos (CPF) is used to control pest worldwide. We have previously reported that 50 mu M CPF induces ROS generation and produces cell cycle arrest followed by cell death. The present investigation was designed to identify the pathway involved in CPF-inhibited cell proliferation in MCF-7 and MDA-MB-231 breast cancer cell lines. In addition, we determined if CPF-induced oxidative stress is related to alterations in antioxidant defense system. Finally we studied the molecular mechanisms underlying in the cell proliferation inhibition produced by the pesticide. In this study we demonstrate that CPF (50 mu M) induces redox imbalance altering the antioxidant defense system in breast cancer cells. Furthermore, we found that the main mechanism involved in the inhibition of cell proliferation induced by CPF is an increment of p-ERK1/2 levels mediated by H2O2 in breast cancer cells. As PD98059 could not abolish the increment of ROS induced by CPF, we concluded that ERK1/2 phosphorylation is subsequent to ROS production induced by CPF but not the inverse. Published by Elsevier Ltd.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 50 条
  • [31] TGFR and ERK1/2 pathways regulate homotypic breast cancer cell aggregation
    Dittmer, A.
    Schunke, D.
    Thomssen, C.
    Dittmer, J.
    ONKOLOGIE, 2008, 31 : 154 - 154
  • [32] Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
    Taylor, A. P.
    Leon, E.
    Goldenberg, D. M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 82 - 89
  • [33] Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
    A P Taylor
    E Leon
    D M Goldenberg
    British Journal of Cancer, 2010, 103 : 82 - 89
  • [34] Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation
    Khan, Naim A.
    Nishimura, Kazuhiro
    Aires, Virginie
    Yamashita, Tomoko
    Oaxaca-Castillo, David
    Kashiwagi, Keiko
    Igarashi, Kazuei
    JOURNAL OF LIPID RESEARCH, 2006, 47 (10) : 2306 - 2313
  • [35] Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway
    Hou, Helei
    Ge, Chao
    Sun, Hefen
    Li, Hong
    Li, Jinjun
    Tian, Hua
    CANCER SCIENCE, 2018, 109 (04): : 1088 - 1100
  • [36] Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines
    Kiss, Eva
    Forika, Gertrud
    Mohacsi, Reka
    Nemeth, Zsuzsanna
    Krenacs, Tibor
    Dank, Magdolna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [37] Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines
    Braeutigam, Karen
    Kabore-Wolff, Elodie
    Hussain, Ahmad Fawzi
    Polack, Stephan
    Rody, Achim
    Hanker, Lars
    Koester, Frank
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (10) : 2923 - 2933
  • [38] Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines
    Karen Bräutigam
    Elodie Kabore-Wolff
    Ahmad Fawzi Hussain
    Stephan Polack
    Achim Rody
    Lars Hanker
    Frank Köster
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2923 - 2933
  • [39] Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway
    Liu, Zhibiao
    Jin, Xin
    Pi, Wen
    Liu, Shouhou
    BIOSCIENCE REPORTS, 2017, 37
  • [40] BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
    Chen, Sihan
    Li, Zhangyun
    Wang, Yanyan
    Fan, Shaohua
    FRONTIERS IN ONCOLOGY, 2022, 12